Infectología y Geriatría Dr. Calderón Bejarano

17/09/2021

Safety & immunogenicity of a booster dose of BNT162b2 given 7 to 9 mos after two-dose series suggest that a third dose could prolong protection and further increase the breadth of protection. https://nej.md/2Z150g3

26/08/2021

https://annalsofintensivecare.springeropen.com/track/pdf/10.1186/s13613-021-00914-5.pdf

14/08/2021

09/07/2021

04/12/2020

Antibiotics provide no additional benefit in patients with sepsis related to COVID-19: https://hubs.ly/H0B_yRV0

18/03/2020

06/03/2020

23/02/2020

This JAMA Insights summarizes prevention and management recommendations for women with recurrent urinary tract infections (UTIs) and proposes individualizing approaches by age and menopausal status, underlying conditions (eg, diabetes), risk of pyelonephritis/sepsis, and patient preferences.

09/02/2020

Comparing 2019-nCoV with SARS-CoV and MERS-CoV.
In the case of 2019-nCoV cases, 6,196 are in severe conditions which may increase the case fatality rate in the future.